Core Viewpoint - The article discusses the investment potential of ODD, highlighting the author's positive outlook based on personal investment positions and analysis [1]. Group 1 - The author holds a beneficial long position in ODD shares, indicating confidence in the company's future performance [1]. - The article expresses personal opinions and analysis without external compensation, suggesting an independent viewpoint [1]. - There is no business relationship with any company mentioned, reinforcing the objectivity of the analysis [1]. Group 2 - The article does not provide specific financial data or performance metrics related to ODD or the broader industry [2]. - No recommendations or advice are given regarding investment suitability, emphasizing a neutral stance on investment decisions [2]. - The authorship includes both professional and individual investors, indicating a diverse range of perspectives in the analysis [2].

Core Insights - ODDITY Tech Ltd. reported strong Q2 2025 results, with net sales and earnings exceeding estimates and showing year-over-year growth [1][3] - The company raised its full-year outlook, driven by robust top-line growth and strategic investments in innovation [2] Financial Performance - Adjusted EPS for Q2 was 92 cents, beating the estimate of 88 cents, and increased by 12.2% year-over-year [3] - Net sales reached $241.1 million, surpassing the estimate of $239 million, and grew by 25.1% from $192.8 million in the prior year [3] - Online DTC sales rose by 29.6% to $235.2 million, constituting 98% of total sales, up from 94% in the previous year [4] Margin and Cost Analysis - Gross profit was $174.4 million, a 25.3% increase from $139.1 million last year, with a gross margin of 72.3% [5] - SG&A expenses increased by 36.3% to $117.3 million, representing 48.6% of net sales, up 200 basis points year-over-year [5] - Operating income was $57.1 million, a 7.6% increase, while the operating margin declined to 23.7% [6] Strategic Developments - ODDITY's core brands, IL MAKIAGE and SpoiledChild, achieved double-digit online sales growth, supported by AI-driven personalization [10] - The company is on track to launch Brand 3 in Q4 2025, targeting the medical-grade dermatology segment, and Brand 4 is expected to launch in 2026 [11] - ODDITY raised $600 million through its first exchangeable note offering, indicating strong investor confidence [12] Future Guidance - For FY25, ODDITY expects net sales between $799 million and $804 million, reflecting 23-24% year-over-year growth [13] - Adjusted EBITDA is projected between $160 million and $162 million, with adjusted EPS expected between $2.06 and $2.09 [14] - For Q3 2025, net sales are anticipated to be between $144 million and $146 million, indicating year-over-year growth of 21-23% [14] Financial Health - As of June 30, 2025, ODDITY had cash and cash equivalents of $656.8 million, no long-term debt, and shareholders' equity of $351.2 million [9]

Financial Data and Key Metrics Changes - In Q2 2025, the company achieved a revenue growth of 26% to $509 million, generated adjusted EBITDA of $122 million, and free cash flow of $99 million, surpassing the entire free cash flow delivered in 2023 [4][30] - The adjusted diluted earnings per share for Q2 was $0.92, exceeding the guidance of $0.85 to $0.89 [29] - Gross margin expanded to 72.3%, exceeding guidance of 70.5% [28] Business Line Data and Key Metrics Changes - The company reported double-digit online growth in both its brands, Il Makiage and Spoiled Child, with Il Makiage expected to reach $1 billion in revenue by 2028 [12][24] - Spoiled Child is projected to cross $200 million in revenue this year, having launched only three years ago [13][42] Market Data and Key Metrics Changes - International sales represented approximately 15% of total net revenue, with a growth of over 40% in the first half of 2025, amounting to around $85 million [25][62] - The company is focusing on expanding its international presence, particularly in markets like the UK, Germany, Canada, Australia, and Israel, where it aims to replicate its U.S. success [27][62] Company Strategy and Development Direction - The company aims to become one of the largest beauty companies globally, with a focus on expanding its product offerings into healthcare, starting with dermatology [5][15] - Investments are being made in technology and new brands, with a strong emphasis on innovation and consumer demand for high-efficacy products [8][14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving another record-breaking year in 2025, with expected net revenue between $799 million and $804 million, representing a year-over-year growth of 23% to 24% [32] - The company plans to front-load investments in 2026, which may impact EBITDA margins in the first half of the year but is expected to maintain a long-term growth algorithm of 20% revenue growth and 20% adjusted EBITDA margin [34] Other Important Information - The company successfully issued its first convertible exchangeable note, upsized to $600 million, which significantly increased its cash position to $815 million [31] - The company is preparing for the launch of Brand Three, which will enter the medical-grade space, focusing on dermatology and offering both OTC and prescription products [13][15] Q&A Session Summary Question: What is driving the sequential compression in gross margin for Q3? - Management explained that gross margin is not a primary metric managed by teams, who focus on contribution margin, and that seasonality and lower revenue dollars in Q3 and Q4 contribute to the compression [39][40] Question: Will the company constrain growth on existing brands to manage future growth? - Management confirmed that they often constrain growth to ensure sustainable long-term growth, maintaining a commitment to 20% revenue growth and 20% adjusted EBITDA margin [51][52] Question: What are the investment plans for Brand Three and expected returns? - Management indicated that significant investments are being made in new brands and technology, with expectations of substantial future returns similar to past successful launches [56][57] Question: What are the growth drivers for international markets? - Management highlighted that international markets could be as large as the U.S. business, with strong growth in established markets and potential in new testing markets [62] Question: How will the go-to-market strategy differ for Brand Three? - Management stated that while the strategy will leverage existing technology and user base, it will also incorporate personalized treatments developed over two years [71][72] Question: What long-term revenue streams are anticipated from Brand Three? - Management outlined that Brand Three will operate as a telehealth platform with medical-grade products, focusing on compliance and leveraging existing user data for product development [78][80]

Financial Data and Key Metrics Changes - In Q2 2025, the company achieved a revenue growth of 26% to $509 million, generated adjusted EBITDA of $122 million, and free cash flow of $99 million, surpassing the entire free cash flow delivered in 2023 [5][25][32] - The adjusted EBITDA margin for Q2 was 28.8%, which compressed by approximately 350 basis points due to planned growth investments [31] - The gross margin expanded by 10 basis points year over year to 72.3%, exceeding guidance of 70.5% [30] Business Line Data and Key Metrics Changes - The company reported double-digit online growth in both its brands, Il Makiage and Spoiled Child, contributing to the overall revenue increase [26][10] - Il Makiage is on track to reach $1 billion in revenue by 2028, with international sales representing 15% of the business in 2024 [13][29] - Spoiled Child is projected to cross $200 million in revenue this year, having launched only three years ago [14] Market Data and Key Metrics Changes - International sales grew over 40% in the first half of 2025, amounting to approximately $85 million, with $75 million from established markets and $10 million from new testing markets [66] - The company is focusing on expanding its presence in international markets, which currently represent a smaller portion of its overall revenue compared to competitors [29][66] Company Strategy and Development Direction - The company aims to become one of the largest beauty companies globally, with a focus on expanding its online presence and entering the healthcare market [6][7] - Upcoming launches include Brand three, which will focus on medical-grade dermatology products, and Brand four next year [14][35] - Investments in technology and new brands are prioritized to sustain long-term growth and innovation [12][58] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving 20% revenue growth and 20% adjusted EBITDA margin in the long term, even without contributions from new brands [34][44] - The company is preparing for a strong finish to 2025, driven by a backlog of repeat sales and a focus on long-term initiatives [11][34] Other Important Information - The company generated $99 million in free cash flow in the first half of 2025, converting over 80% of adjusted EBITDA into free cash [32] - The company has a remaining buyback authorization of $103 million with no share repurchases year to date [33] Q&A Session Summary Question: What is driving the sequential compression in gross margin for Q3? - Management explained that gross margin is not a primary metric they manage to, and seasonal factors contribute to lower margins in the second half of the year due to repeat business dynamics [40][42] Question: Will Brand three's success impact growth management for existing brands? - Management confirmed that they do not need Brand three for their 2025 or 2026 outlook, as existing brands have sufficient growth potential [44][45] Question: What is the strategy for Brand three's launch? - Management indicated that a soft launch will occur in Q3 to test the market, with a full launch planned for Q4 [52] Question: What are the growth drivers for international markets? - Management highlighted that international markets are expected to grow significantly, with a focus on deeper penetration and new market entries [63][66] Question: How does Brand three differ from previous launches? - Management noted that Brand three will leverage advanced technology and personalized treatment plans, setting it apart from traditional offerings [72][74]

Financial Highlights - The company's net revenue reached $815 million (LTM Q2 2025)[11] - The company's adjusted EBITDA reached $130 million (LTM Q2 2025)[11] - The company's cash, cash equivalents & investments reached $752 million as of June 30, 2025[11, 12] - The company's net revenue growth was +26% year-over-year (LTM Q2 2025)[11] - The company's adjusted EBITDA margin was 22% (LTM Q2 2025)[11] Growth and Profitability - The company's net revenue grew from $223 million in FY21 to $647 million in FY24, with an estimated $799-804 million in FY25[14] - The company's adjusted EBITDA grew from $27 million in FY21 to $150 million in FY24, with an estimated $160-162 million in FY25[14] - The company's net revenue growth rates were +57% in FY22, +46% in FY23, and +23-24% in FY24[14] Q2 2025 Performance - The company's Q2 2025 net revenue was $241 million, a +25% increase compared to Q2 2024[21] - The company's Q2 2025 gross margin was 72.3%, a +10 bps increase compared to Q2 2024[21] - The company's Q2 2025 adjusted EBITDA was $70 million, a +12% increase compared to Q2 2024[21] - The company's Q2 2025 adjusted diluted EPS was $0.92, a +12% increase compared to Q2 2024[21] Financial Outlook - The company's FY 2025 net revenue is projected to be $799 to 804 million, representing a 23 to 24% growth[19] - The company's FY 2025 adjusted EBITDA is projected to be $160 to 162 million[19]

Core Viewpoint - Oddity Tech reported quarterly earnings of $0.92 per share, exceeding the Zacks Consensus Estimate of $0.88 per share, and showing an increase from $0.82 per share a year ago, indicating a positive earnings surprise of +4.55% [1] Financial Performance - The company achieved revenues of $241.14 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.83% and reflecting a year-over-year increase from $192.77 million [2] - Over the last four quarters, Oddity Tech has consistently surpassed consensus EPS and revenue estimates [2] Stock Performance - Oddity Tech shares have increased approximately 70.6% since the beginning of the year, significantly outperforming the S&P 500's gain of 6.1% [3] Future Outlook - The company's earnings outlook will be crucial for assessing future stock performance, with current consensus EPS estimates at $0.32 for the coming quarter and $2.04 for the current fiscal year [7] - The Zacks Rank for Oddity Tech is currently 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6] Industry Context - The Internet - Software industry, to which Oddity Tech belongs, is currently ranked in the top 32% of over 250 Zacks industries, suggesting a favorable environment for stock performance [8]

Financial Performance - Second quarter net revenue reached $241 million, a 25% increase year-over-year from $193 million[6] - Gross profit for the second quarter was $174 million, also reflecting a 25% year-over-year increase, with a gross margin of 72.3%[8] - Adjusted EBITDA for the second quarter was $70 million, representing a 12% increase from $62 million in the same quarter of the previous year[8] - The company raised its full year 2025 outlook to a net revenue range of $799-804 million, indicating year-over-year growth of 23-24%[11] - The third quarter 2025 guidance includes net revenue expectations of $144-146 million, representing year-over-year growth of 21-23%[13] - Adjusted diluted EPS for the second quarter was $0.92, up from $0.82 in the same quarter of the previous year[8] - Net revenue for Q2 2025 reached $241,140,000, a 25% increase from $192,774,000 in Q2 2024[24] - Gross profit for the first half of 2025 was $375,200,000, up 27% from $295,203,000 in the same period of 2024[24] - The company reported a net income of $49,285,000 for Q2 2025, representing an 8% increase compared to $45,491,000 in Q2 2024[24] - Adjusted EBITDA for the first half of 2025 was $121,920,000, an increase from $110,442,000 in the same period of 2024[30] Cash Position and Assets - The company completed its first exchangeable note offering, upsized to $600 million with a 0% coupon, enhancing its cash position[7] - As of June 30, 2025, ODDITY reported cash, cash equivalents, and investments totaling $815 million, along with undrawn credit facilities of $200 million[7] - Cash and cash equivalents surged to $656,822,000 as of June 30, 2025, compared to $50,340,000 at the end of 2024[25] - Total assets increased to $1,097,899,000 as of June 30, 2025, significantly up from $438,882,000 at the end of 2024[26] - The company generated $101,384,000 in net cash from operating activities for the first half of 2025, slightly down from $105,440,000 in the same period of 2024[27] - Free cash flow for the first half of 2025 was $99,433,000, compared to $103,938,000 in the first half of 2024[31] - The company issued exchangeable notes generating proceeds of $583,500,000 during the first half of 2025[27] Business Expansion and Strategy - ODDITY is progressing towards the launch of Brand 3 in the fourth quarter of 2025, expanding into medical grade products[4] - The company is focusing on international expansion and the ongoing development of the ODDITY LABS molecule discovery platform[7] - Online direct-to-consumer sales accounted for 98% of net revenue in Q2 2025, totaling $235,161,000, up from 94% in Q2 2024[33]

Core Insights - ODDITY Tech Ltd. reported strong financial results for Q2 2025, exceeding guidance across revenue, profit, and earnings per share, indicating robust business growth and profitability [2][4][6] - The company is expanding into new markets, particularly in healthcare with the upcoming launch of Brand 3, which focuses on medical-grade products [3][4] - ODDITY raised its full-year financial outlook for 2025, reflecting confidence in continued growth driven by a backlog of repeat orders [4][9] Financial Performance - Q2 2025 net revenue reached $241 million, a 25% increase year-over-year from $193 million in Q2 2024 [4][6] - Adjusted EBITDA for Q2 2025 was $70 million, up 12% from $62 million in Q2 2024, with an adjusted EBITDA margin of 28.8% [4][6] - Net income for Q2 2025 was $49 million, compared to $45 million in Q2 2024, with a net income margin of 20.4% [4][6] Financial Outlook - The updated full-year 2025 outlook includes net revenue between $799 million and $804 million, representing year-over-year growth of 23% to 24% [9][10] - For Q3 2025, ODDITY expects net revenue between $144 million and $146 million, with a gross margin of approximately 68% [11][9] - Adjusted diluted EPS for the full year is projected to be between $2.06 and $2.09, an increase from the previous outlook [9][10] Strategic Initiatives - The company is progressing towards the formal launch of Brand 3 in Q4 2025 and Brand 4 in 2026, indicating a focus on innovation and market expansion [5][4] - ODDITY is also developing its ODDITY LABS molecule discovery platform, which may enhance its product offerings in the future [5][4] - The company completed its first exchangeable note offering, upsized to $600 million, strengthening its cash position [5][4]

Core Insights - Oddity Tech (ODD) is set to announce its second-quarter 2025 results on August 4, with expected non-GAAP earnings between $0.85 and $0.89 per share and revenues anticipated between $235 million and $239 million [1][9] Earnings Expectations - The Zacks Consensus Estimate for second-quarter earnings is at $0.88 per share, reflecting a year-over-year growth of 7.3%, while the revenue consensus is $239.2 million, indicating a 24.1% year-over-year increase [2] Historical Performance - ODD has consistently exceeded the Zacks Consensus Estimate in the past four quarters, achieving an average surprise of 32.8% [2] Growth Drivers - The company is expected to benefit from a growing user base, an expanding online presence, and a strong direct-to-consumer (DTC) platform, which are anticipated to drive revenue growth [4] - Strong demand for IL Makiage and SpoiledChild brands is likely to contribute positively to revenue in the upcoming quarter [5][9] Margin Considerations - Despite the expected revenue growth, gross margins may be negatively impacted by higher tariffs, which are projected to affect margins by 50 to 100 basis points [5][9] Earnings Prediction Model - According to the Zacks model, ODD has a positive Earnings ESP of +1.14% and a Zacks Rank of 1 (Strong Buy), indicating a favorable outlook for an earnings beat [6]

Core Viewpoint - The market anticipates Oddity Tech (ODD) to report a year-over-year increase in earnings driven by higher revenues, with a focus on how actual results compare to estimates [1][2]. Earnings Expectations - Oddity Tech is expected to report quarterly earnings of $0.88 per share, reflecting a year-over-year increase of +7.3% [3]. - Revenues are projected to reach $237.22 million, representing a 23.1% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate for Oddity Tech has remained unchanged over the last 30 days, indicating stability in analyst expectations [4]. - The Most Accurate Estimate for Oddity Tech is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +0.29% [11]. Earnings Surprise History - In the last reported quarter, Oddity Tech exceeded the expected earnings of $0.63 per share by delivering $0.69, resulting in a surprise of +9.52% [12]. - The company has beaten consensus EPS estimates in each of the last four quarters [13]. Industry Context - In the Zacks Internet - Software industry, F5 Networks (FFIV) is expected to report earnings of $3.49 per share, with a year-over-year change of +3.9% and revenues of $753.06 million, up 8.3% from the previous year [17]. - F5 Networks has a negative Earnings ESP of -0.33%, making it challenging to predict a beat on the consensus EPS estimate, despite having beaten estimates in the last four quarters [18].